Wren Labs Launches Neuroendocrine Tumor Liquid Biopsy in Asia, Works on Expanding Testing Menu
The Branford, Connecticut-based company is preparing to launch a prostate cancer liquid biopsy test while in early discussions to expand its existing test into Japan.